BiotechTubeBiotechTube
Home/Unity Biotechnology/Nathaniel "Ned" David
N"

Nathaniel "Ned" David

Co-founder, former President & CSO

Unity Biotechnology

Therapeutic Areas

OphthalmologyNeurologyAge-Related Diseases

Unity Biotechnology Pipeline

DrugIndicationPhase
UBX1325 (foselutoclax)Diabetic Macular Edema (DME)Phase 2b
UBX0101Osteoarthritis of the KneePhase 2
UBX1967Ophthalmology (Undisclosed)Preclinical
CNS ProgramsUndisclosed Neurological DiseasesDiscovery/Preclinical

Leadership Team at Unity Biotechnology

AG
Anirvan Ghosh
Chief Executive Officer
JD
Jamie Dananberg
Chief Medical Officer
MP
Michael P. Samar
Chief Development Officer
DL
David L. Lacey
Strategic Advisor, Former Interim CEO
KC
Keith C. Leonard, Jr.
Chairman of the Board of Directors
NH
Natalie Holles
Director
R(
Robert (Bob) Nelsen
Director
A(
Alexander (Sandy) R. Thessin
Director
JC
Judith Campisi
Co-founder, Scientific Advisory Board
JV
Jan van Deursen
Co-founder
View full Unity Biotechnology profile